IC
AGN

Inverness Counsel’s Allergan plc AGN Stock Holding History

Inverness Counsel’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-114,213
Closed -$26.3M – 96
2016
Q3 		$26.3M Buy
114,213
+4,197
+4% +$1.03M 2.07% 15
2016
Q2 		$25.4M Buy
110,016
+9,265
+9% +$2.14M 1.98% 17
2016
Q1 		$27M Sell
100,751
-1,340
-1% -$384K 2.09% 18
2015
Q4 		$31.9M Buy
102,091
+1,852
+2% +$551K 2.42% 10
2015
Q3 		$27.2M Sell
100,239
-23,925
-19% -$7.35M 2.31% 15
2015
Q2 		$37.7M Buy
124,164
+5,774
+5% +$1.72M 2.73% 7
2015
Q1 		$35.2M Buy
+118,390
New +$33.8M 2.59% 8

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Inverness Counsel's AGN Position: Q4 2016 in Review

Inverness Counsel sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 114,213 shares — an estimated $26.3M sold.

Inverness Counsel first reported a position in AGN in Q1 2015 and held it in 7 quarters. The position peaked at $37.7M in Q2 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Inverness Counsel reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Inverness Counsel sold 114,213 Allergan plc shares in Q4 2016, an estimated $26.3M.
  • Inverness Counsel first reported a position in Allergan plc in Q1 2015 and held it in 7 quarters.
  • Inverness Counsel's Allergan plc position peaked at $37.7M in Q2 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Inverness Counsel's 13F filing for Q4 2016, filed 2 Feb 2017.